CARDIOVASCULAR RISK AND CHRONIC KIDNEY DISEASE: CARDIO-NEPHROPROTECTION STRATEGIES

CARDIOVASCULAR RISK AND CHRONIC KIDNEY DISEASE: CARDIO-NEPHROPROTECTION STRATEGIES

.

Saved in:

Bibliographic Details
Main Authors:	V. C. Moiseev, N. A. Mukhin, A. V. Smirnov, J. D. Kobalava, I. N. Bobkova, S. V. Villevalde, M. A. Yefremovtseva, L. V. Kozlovskaya, M. Yu. Shvetsov, M. V. Shestakova, G. P. Arutyunov, S. A. Boytsov, A. S. Galyavich, Y. I. Greenstein, V. A. Dobronravov, O. M. Drapkina, V. M. Ermolenko, Yu. A. Karpov, I. G. Kayukov, J. V. Kotovsky, V. V. Kukharchuk, A. I. Martynov, T. E. Morozova, R. G. Oganov, V. I. Podzolkov, L. Ya. Rozhinskaya, S. N. Tereshchenko, V. V. Fomin, V. N. Khirmanov, I. E. Chazova, M. Sh. Shamkhalova, E. M. Shilov, E. V. Shlyakhto, A. M. Shutov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2014-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/130
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phytotherapeutic drugs with nephroprotective activity (review)
by: Podpletnyaia E.A., et al.
Published: (2017-04-01)

Nephroprotective strategy in the treatment of hypertension as a modern general medical problem
by: V. I. Podzolkov, et al.
Published: (2018-12-01)

Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data
by: A. I. Listratov, et al.
Published: (2024-10-01)

Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board
by: M. V. Shestakova, et al.
Published: (2023-11-01)

Monoclonal Gammopathy of Renal Significance: Consensus of Hematologists and Nephrologists of Russia on the Establishment of Nosology, Diagnostic Approach and Rationale for Clone Specific Treatment
by: A. V. Smirnov, et al.
Published: (2020-03-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)

Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders
by: O. A. Gromova, et al.
Published: (2024-02-01)

Simultaneous pancreas‐kidney transplantation in type 1 diabetes mellitus. Clinical options
by: A. S. Severina, et al.
Published: (2020-08-01)

The role of nitric oxide in nephroprotection during surgical correction of congenital heart disease in children (literature review)
by: P. V. Zinchuk, et al.
Published: (2024-12-01)

Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy
by: A. D. Gavrilko, et al.
Published: (2023-11-01)

Enhancing parameters of silicon varactors using laser gettering
by: I. M. Vikulin, et al.
Published: (2018-04-01)

Compliance of the management of hospitalized patients with heart failure with the quality criteria for health care: data from the St. Petersburg registry
by: G. V. Endubaeva, et al.
Published: (2023-12-01)

Correction of hypertriglyceridemia in order to reduce the residual risk in atherosclerosis-related diseases. Expert Council Opinion
by: G. P. Arutyunov, et al.
Published: (2019-09-01)

The role of free radical oxidation in the kidneys in the nephroprotective action of eplerenone, a mineralocorticoid receptor antagonist, in experimental diabetes mellitus
by: A. Yu. Zharikov, et al.
Published: (2021-07-01)

Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics
by: G. P. Arutyunov, et al.
Published: (2019-05-01)

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2015-09-01)

DYNAMICS OF DAILY BLOOD PRESSURE RHYTHM AND HEART RATE VARIABILITY IN PATIENTS WITH ARTERIAL HYPERTENSION DURING A NEW FORM OF NIFEDIPINE (NIFECAD XL) TREATMENT
by: N. A. Mukhin, et al.
Published: (2003-12-01)

MEDICAL-AND-SOCIAL CHARACTERISTICS OF TEENAGERS AND YOUNG MEN BOTH BELOW THE CONSCRIPTION AGE AND DUE FOR CONSCRIPTION IN THE KRASNODAR TERRITORY
by: S. N. LINCHENKO, et al.
Published: (2017-05-01)

Сolor Doppler Imaging in Eye Hemodynamics Evaluation in Syndrome of Thrombotic Microangiopathy
by: T. V. Smirnova, et al.
Published: (2019-01-01)

Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic
by: E. V. Shlyakho, et al.
Published: (2020-04-01)

Association of medical staffing and outcomes in cardiovascular diseases
by: S. V. Villevalde, et al.
Published: (2021-01-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Up-to-Date Aspects of Antihypertensive Therapy from the Viewpoint of Cardioand Nephroprotective Action: Olmesartan
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

Clinical significance of assessing the subpopulation composition of blood lymphocytes in patients with infectious corneal lesions in high-risk keratoplasty
by: V. V. Neroev, et al.
Published: (2020-09-01)

EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: A. Catapano, et al.
Published: (2013-08-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
by: V. V. Fomin
Published: (2013-08-01)

Patients with hypertension and chronic kidney disease as a priority group for primary prevention programs
by: E. A. Medvedeva, et al.
Published: (2024-04-01)

RISK FACTORS OF ARRHYTHMIAS IN PATIENTS WITH ACUTE DECOMPENSATION OF CHRONIC HEART FAILURE
by: N. V. Larionova, et al.
Published: (2017-09-01)

Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

New, long-acting form of nifedipine: efficacy and safety in patients with mild to moderate arterial hypertension
by: E. V. Alimova, et al.
Published: (2004-08-01)

THE VALUE OF PET/CT IN THE DIAGNOSIS, STADING AND MONITORING OF COLORECTAL CANCER
by: V. I. Chernov, et al.
Published: (2019-09-01)

Neonatal meconium aspiration: risk factors and adaptation by the newborns
by: I. M. Bogomazova, et al.
Published: (2019-02-01)

ICD-10 code-based definition of heart failure in Saint Petersburg electronic health records: prevalence, health care utilization and outcomes
by: A. E. Soloveva, et al.
Published: (2021-10-01)

Rationale and design of multicenter prospective observational study of types, GRAde, VariabilITY, associations and prognosis of orthostatic responses in Heart Failure (GRAVITY-HF)
by: E. V. Shlyakhto, et al.
Published: (2020-02-01)

Resistance to antibacterial drugs and bacteriophages of Klebsiella pneumoniae isolates isolated from children of different ages with intestinal infections
by: N. V. Gonchar, et al.
Published: (2023-04-01)

Antioxidant agent Probucol beneficial influence on incidence and severity of coronary artery restenosis after transluminal balloon coronary angioplasty
by: A. I. Kaminny, et al.
Published: (2006-10-01)

Various doses of statins and coronary angiogenesis in patients with coronary heart disease
by: I. V. Sergienko, et al.
Published: (2009-10-01)

Identification and quantification of flavonoids and hydroxycinnamic acids in yellow wood anemone (<i>Anemone ranunculoides</i> L.) by UHPLC-DAD-HESI/MS analysis
by: A. N. Luferov, et al.
Published: (2024-06-01)

Trends in the epidemiology of chronic kidney disease in patients with diabetes in Russian Federation according to the Federal diabetes register (2010–2022)
by: M. S. Shamkhalova, et al.
Published: (2023-11-01)